Search Results
Adaptive Immune Resistance to Intravesical BCG in NMIBC: BCG-Unresponsive Clinical Trials
Management of BCG Unresponsive Cystectomy Ineligible Bladder Cancer Patients Pembrolizumab
Emerging salvage therapies for BCG-unresponsive non-muscle invasive bladder cancer
Urowebinar: BCG unresponsive disease how this definition impact your treatment decision making
Treatment of high risk nMIBC in era of BCG shortage - EMPIRE Urology Lecture Series
Safety & efficacy of nadofaragene firadenovec for patients with high-grade, BCG unresponsive NMIBC
Management of BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Case 1: Treatments for NMIBC Refractory to BCG
Barriers to Clinical Trials for Non-Muscle Invasive Bladder Cancer
Checkpoint Inhibitors for NMIBC
Immunotherapy as Salvage Treatment for Non-Muscle-Invasive Bladder Cancer
BCG Failure Defining and Managing Difficult Patients
